A Comparative Study between Topical 5% Minoxidil and Topical “Redensyl, Capixyl, and Procapil” Combination in Men with Androgenetic Alopecia

[Audio] The study, conducted by Karaca and Akpolat, aimed to compare the effectiveness and safety of two treatments for Androgenetic Alopecia in adult men. The treatments being compared were a combination of topical "Redensyl, Capixyl, and Procapil" and 5% minoxidil. The study used a randomized controlled design and included male patients suffering from Androgenetic Alopecia. The results showed that the group treated with the combination of Redensyl, Capixyl, and Procapil had better outcomes in terms of hair growth..

[Audio] The study compares the effectiveness and safety of a combination of topical "Redensyl, Capixyl, and Procapil" with 5% minoxidil in adult men with androgenetic alopecia. Finasteride is an inhibitor of 5-AR that inhibits miniaturization of hair follicles and increases the production of DHT. Oral finasteride has potential risks such as gynecomastia, feminization, and impotence. Both 1 mg oral finasteride and 5% topical minoxidil are considered safe and effective treatments, with oral finasteride being more effective in patients with moderately severe androgenetic alopecia. A combination of minoxidil and finasteride shows better outcomes compared to their individual use. The active raw materials of Redensyl, Capixyl, and Procapil were added to the system and mixed. The topical RCP was formulated at the Cosmetic Studies Unit R&D Department, Faculty of Pharmacy, Yeditepe University, and all the rights of this RCP combination are reserved by the Turkish Patent Institute under the name Procare..

[Audio] The study published by Karaca and Akpolat in 2019 compared the effectiveness and safety of a combination of topical Redensyl, Capixyl, and Procapil (RCP) with 5% minoxidil in men with androgenetic alopecia. Patients were asked to rate their bald area and overall opinion of their hair at the start of the study and after 12 and 24 weeks of treatment. Researchers evaluated changes in hair growth and intensity-dependent head skin coverage. The results showed that the RCP group had better hair growth and a greater improvement in hair condition compared to the minoxidil group. Statistical tests confirmed the significance of these findings. The study suggests that the combination of Redensyl, Capixyl, and Procapil is a more effective and safe option for men with androgenetic alopecia compared to 5% minoxidil..

[Audio] The study found that the group treated with RCP had significantly better recovery compared to the group treated with topical minoxidil..

[Audio] The researchers conducted a comparative study between topical 5% minoxidil and topical "Redensyl, Capixyl, and Procapil" combination in men with androgenetic alopecia. Of the 120 individuals enrolled in the study, 106 completed it. The researcher evaluation showed significantly better recovery in the group treated with RCP than in the group that received minoxidil treatment. In the patients with AGA, a seven-point global photographic evaluation scale was used to evaluate their hair growth. Treatment hair growth scoring and hair loss scoring were also used to assess the effectiveness of the treatments. The results showed that the RCP group had a higher score for hair growth and lower score for hair loss compared to the minoxidil group. The study concluded that the RCP combination was more effective in treating androgenetic alopecia than minoxidil..

[Audio] The study compared the use of a combination of topical Redensyl, Capixyl, and Procapil with 5% minoxidil in men with androgenetic alopecia. The results showed that the group using the RCP combination had better hair growth outcomes. The study found that Redensyl, Procapil, and Capixyl in appropriate stoichiometric combination performed better than 5% minoxidil in promoting hair growth. The results showed that 64.7% of volunteers in the RCP group showed significant or moderate recovery compared to only 25.5% in the minoxidil group. At the end of the 24-week treatment period, the hair recovery in the RCP group was 2.54 times higher than in the minoxidil group, a significant difference. The global photographic evaluation also showed a higher recovery rate in the RCP group (88.9%) compared to the minoxidil group (60%). In conclusion, this study found that the combination of Redensyl, Procapil, and Capixyl in appropriate stoichiometric ratio may provide better results in terms of hair growth compared to 5% minoxidil. Our findings support the potential use of this combination as a treatment for androgenetic alopecia..

[Audio] The study aimed to compare the effectiveness and safety of a combination of topical "Redensyl, Capixyl, and Procapil" with 5% minoxidil in adult men with androgenetic alopecia. The findings indicated that the RCP group demonstrated superior outcomes regarding hair growth. Various research studies were cited, underscoring the positive impacts of minoxidil and other hair growth treatments. These studies emphasized the significance of proper treatment and maintenance in managing androgenetic alopecia. Additionally, the regulation of cellular activity was discussed, highlighting the crucial role of the extracellular matrix in balancing cell growth and death. The study also noted the importance of a well-balanced diet, citing the example of zinc deficiency impeding cystine incorporation into skin proteins. Furthermore, the antioxidant properties of green tea polyphenols were mentioned, suggesting their potential in protecting against free radical damage to hair. Overall, the combination of topical RCP and minoxidil showed promising results in promoting hair growth for men with androgenetic alopecia, and the inclusion of matrikines, plant molecules, a balanced diet, and green tea polyphenols may further support healthy hair growth..